Steven Cohen's TLX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 18,409 shares of Telix Pharmaceuticals Limited (TLX) worth $137,883, representing 0.00% of the portfolio. First purchased in 2025-Q4, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Steven Cohen has initiated a new position in TLX, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Telix Pharmaceuticals Limited (TLX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Telix Pharmaceuticals Limited (TLX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +18,409 | New Buy | 18,409 | $7.49 |
Steven Cohen's Telix Pharmaceuticals Limited Investment FAQs
Steven Cohen first purchased Telix Pharmaceuticals Limited (TLX) in Q4 2025, acquiring 18,409 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Telix Pharmaceuticals Limited (TLX) for 1 quarters since Q4 2025.
Steven Cohen's largest addition to Telix Pharmaceuticals Limited (TLX) was in Q4 2025, adding 18,409 shares worth $137,883.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 18,409 shares of Telix Pharmaceuticals Limited (TLX), valued at approximately $137,883.
As of the Q4 2025 filing, Telix Pharmaceuticals Limited (TLX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Telix Pharmaceuticals Limited (TLX) was 18,409 shares, as reported at the end of Q4 2025.